VE和L-肌肽对大菱鲆幼鱼生长、抗氧化、非特异性免疫及血清生化指标的影响

实验以大菱鲆（Scophthalmus maximus）幼鱼[（14.00±0.02）g]为研究对象,采用2×4双因素设计,设2个VE水平（0和75 mg/kg）和4个L-肌肽水平（0、50、100和200 mg/kg）,研究VE和L-肌肽对其生长、抗氧化、非特异性免疫及血清生化指标的影响。实验共分8组,每组3个重复,每个重复46尾鱼,实验周期为8周。结果显示:（1）在饲料中添加75 mg/kg VE显著提高了大菱鲆幼鱼增重率（WGR）和特定生长率（SGR）（P < 0.05）,L-肌肽添加量≤100 mg/kg对实验鱼生长性能无显著影响（P>0.05）,添加量为200 mg/kg时鱼体WGR、SGR和蛋白质效率（PER）显著降低,饲料系数（FCR）显著升高（P < 0.05）;（2）VE和L-肌肽对血清谷胱甘肽过氧化物酶（GSH-PX）、过氧化氢酶（CAT）活性和丙二醛（MDA）含量及肝脏总抗氧化能力（T-AOC）、超氧化物歧化酶（SOD）活性和MDA含量均具有显著的交互作用（P < 0.05）,在VE 75 mg/kg水平下,L-肌肽添加量为50和100 mg/kg时血清GSH-PX活性最高,L-肌肽添加量为100和200 mg/kg时血清CAT活性最高且与添加量为50 mg/kg差异不显著（P>0.05）,添加100 mg/kg肝脏T-AOC和SOD活性达到最高且50 mg/kg组的SOD与100 mg/kg组差异不显著（P>0.05）,主效应结果显示,VE显著提高了血清T-AOC、SOD及肝脏CAT活性（P < 0.05）,L-肌肽显著提高了血清T-AOC（P < 0.05）;（3）VE和L-肌肽对血清补体C3和LZM活性交互作用显著,在75 mg/kg VE水平下,L-肌肽添加量为50 mg/kg时,补体C3水平最高（P < 0.05）,主效应显示,VE和L-肌肽对血清总蛋白（TP）影响均不显著（P>0.05）;（4）添加VE显著降低了血清总胆固醇（TCHO）和甘油三酯（TG）含量（P < 0.05）,添加L-肌肽显著降低了血清TG含量,且在L-肌肽50 mg/kg时达到最低。综合考虑大菱鲆幼鱼[（14.00-39.43）g]的生长性能、抗氧化性能、非特异性免疫及血清生化指标得出,在实验配方条件下（鱼油70 g/kg,大豆卵磷脂10 g/kg）,添加VE 75 mg/kg时,L-肌肽的适宜添加量为50 mg/kg。     

恩诺沙星对银鲫急性毒性及血液生化指标的影响

为了解恩诺沙星对异育银鲫(Carassius auratus gibelio)的急性毒性及血液生化指标的影响,评价恩诺沙星对异育银鲫的安全性.本实验研究了恩诺沙星对异育银鲫的急性毒性,并观察了恩诺沙星在不同剂量下对异育银鲫血液生化指标的影响.实验结果表明,恩诺沙星对异育银鲫的半数致死剂量为1 949.84 mg/kg,安全剂量为194.98 mg/kg.当恩诺沙星以常规给药剂量(20 mg/kg)连续口灌异育银鲫30 d时,异育银鲫的血清总蛋白含量、谷丙转氨酶含量、谷草转氨酶、γ-谷氨酰转移酶含量与对照组没有显著变化;而当恩诺沙星以40 mg/kg、80 mg/kg、160 mg/kg、320 mg/kg的剂量连续口灌异育银鲫30 d时,异育银鲫的血清谷丙转氨酶含量较对照组分别增加了23％、30％、46％、86％ (P ＜0.05),血清谷草转氨酶含量较对照组分别增加了37％、42％、69％、86％(P＜0.05).本研究确定了恩诺沙星对异育银鲫的安全剂量,证实了恩诺沙星引起异育银鲫出现肝功能失调的剂量范围,对恩诺沙星在异育银鲫养殖中的安全使用提供了科学依据,也证实常规给药剂量(20 mg/kg)的恩诺沙星不会导致异育银鲫出现肝损伤.     

盐度对大麻哈鱼幼鱼血液生化指标及肝组织的影响

模拟大麻哈鱼幼鱼降海洄游水域环境盐度,设0（淡水对照）、5、10、15、20共5个盐度组,以体质量（26.57±6.32）g、全长（14.44±1.05）cm幼鱼分别进行130 d饲养试验,通过血液生化指标分析及肝组织观察,研究了大麻哈鱼降海期对不同盐度适应过程的生理变化.结果表明: 血清渗透压和血清Na⁺、Cl^-变化趋势与水体盐度变化基本一致.高盐度(15、20)组血清Na⁺、Cl^-、Mg²⁺含量与低盐度(5)组和淡水组差异显著;各盐度处理组血清K⁺含量均显著低于淡水组.盐度10组的血糖浓度显著高于盐度5和20组;各盐度处理组总胆汁酸与淡水组差异显著;幼鱼血清总蛋白(TP)、白蛋白(ALB)、球蛋白(GLB)含量随盐度的升高总体呈下降趋势,其中淡水组TP和GLB含量显著高于盐度15和20组.淡水组血清谷丙转氨酶（ALT）、谷草转氨酶(AST)与高盐度组差异显著.低盐度(盐度0、5)下试验幼鱼肝细胞有部分破裂现象,肝组织空泡化严重.各组试验鱼生长和成活率无明显差异,生理生化指标显示大麻哈鱼幼鱼降海期适应盐度以10～20为宜.     

甜菜碱对猪的抗脂肪肝效应

采用不同甜菜碱添加量（0、1000、1250、1500和1750mg/kg）的同种饲料,分别饲喂5组（150头）肥育猪（63kg)40d,对肝脏、血液脂类相关代谢指标进行分析。结果表明:甜菜碱可以提高肝脏卵磷脂含量,其中1250mg/kg组效果最为明显（P＜0.02）,较对照组提高25.29%,游离肉碱和长链脂酰肉碱含量亦显著升高（P＜0.01）,1750mg/kg组二者分别提高了30.18%和44.44%;肝脏脂肪含量呈下降趋势,同时表明,饲料中添加甜菜碱,血清游离脂肪酸含量显著升高,其中1750mg/kg组最为明显（P＜0.01）,提高了21.27%,血清胆固醇含量呈下降趋势（P＜0.05）,1750mg/kg组降低了9.72%,由此可见甜菜碱可以影响肝脏脂肪代谢,并具有一定的抗脂肪肝的作用。     

肾康注射液对链脲佐菌素诱导的大鼠DN的作用研究

目的:研究肾康注射液(SKI)对糖尿病肾病(DN)的作用。方法:采用大鼠腹腔注射链脲佐菌素65 mg/kg体重建立DN大鼠模型,SKI高、中、低分别腹腔注射SKI 10 m L/kg,5 m L/kg,2.5 m L/kg,2次/天;正常组和模型组分别给予生理盐水5 m L/kg,2次/天;8周后,观察、测量相应生化和病理等指标。结果:SKI可明显增强DN大鼠肾脏对血肌酐和血尿素氮的清除率,显著降低血液中总胆固醇、甘油三脂和低密度脂蛋白的含量和升高血液中高密度脂蛋白含量,显著升高血清中T-SOD和CAT的活力,降低血清中NO及MDA含量和降低血清中NOS的活力,显著改善糖尿病引起的肾组织损伤。结论:SKI对治疗DN的治疗作用是肯定的其主要表现在改善血脂代谢紊乱,增强机体抗氧化应激能力及增强肾脏对肌酐和尿素氮的清除能力进而改善肾脏损伤。     

苯并(a)芘与壬基酚对河川沙塘鳢的联合毒性研究

为探究环境内分泌干扰物联合毒性对鱼类的影响,选取苯并芘(benzo[a]pyrene,BaP)及千幕酚(4-nonlyphenol,NP)对河川沙塘鳢Odontobutis potamophila进行单独和联合毒性研究.研究了NP和BaP对河川沙塘鳢血清雌二醇(E2)、卵黄蛋白原(Vtg)、血清谷草转氨酶(GOT)以及肝脏7-乙氧基-3-异吩咏唑酮-脱乙基酶(7-ethoxyresoufin-O-deethylase,EROD)和超氧化物岐化酶(SOD)的影响.结果 表明,BaP单一暴露时,随着BaP剂量浓度的升高雌鱼血清E2含量下降,肝脏EROD活性升高;25 mg/kg BaP试验组雌鱼肝脏EROD活性显著高十对照组;肝脏SOD和血清GOT活性与对照无筹异;NP和BaP联合暴露中,200 mg/kg NP+10 mg/kg BaP、200 mg/kg NP+2 mg/kg BaP试验组雄性个体血清Vtg平均含量比200 mg/kg NP组低50%左右,而血清E2含最显著高于对照组,肝脏EROD酶活性、血清GOT活性变化与BaP剂量浓度呈正相关,而肝脏SOD酶活性则与BaP剂量浓度呈负相关;200 mg/kg NP+25 mg/kg BaP试验组肝脏SOD活性显著低于对照组,而血清GOT活性则显著高于对照组.显示NP和BaP联合作用时BaP可拮抗NP对雄鱼Vtg的诱导效应;200 mg/kg NP+2 mg/kg BaP可导致河川沙塘鳢肝脏肝细胞损伤.     

硫胺素水平对团头鲂幼鱼生长、肝组织沉积量及血液生化指标的影响

为研究硫胺素对团头鲂幼鱼生长、组织沉积量和血液生化指标的影响,试验采用单因素浓度梯度设计,配制了6组等氮等能的半纯合饲料,各组硫胺素含量分别为0、0.51、0.98、1.59、2.13和2.68 mg/kg。选取团头鲂幼鱼720尾[初重为（0.30±0.01）g],按随机原则分为6组,每组4重复,各重复30尾,日投饵3次,饲喂8周后采集样品。结果表明,与对照组相比,0.98、1.59、2.13、和2.68 mg/kg添加组的增重率和特定生长率均显著提高（P < 0.05）。1.59和2.13 mg/kg硫胺素添加组的成活率显著高于对照组（P < 0.05）。随着饲料中硫胺素含量的升高,血浆葡萄糖含量呈现先下降后上升的趋势,血浆葡萄糖水平在1.59 mg/kg时为最小值（P < 0.05）。对照组与0.51 mg/kg硫胺素组相比血浆中丙酮酸含量差异不显著,但显著高于其他试验组（P < 0.05）。以团头鲂幼鱼的增重率和肝脏硫胺素沉积量为评价指标,进行双折线回归分析,饲料中硫胺素适宜添加水平分别为1.48和1.84 mg/kg。     

饲料中添加谷胱甘肽对黄颡鱼幼鱼组织谷胱甘肽含量、免疫及抗氧化性能的影响

研究旨在探讨饲料中添加还原型谷胱甘肽(Glutathione, GSH)对黄颡鱼幼鱼(Pelteobagrus fulvidraco)组织谷胱甘肽含量、免疫及抗氧化性能的影响。选用初始体重为(1.32±0.01) g的黄颡鱼800尾, 随机分为5组, 每组4个重复, 每个重复40 尾鱼, 分别投喂基础饲料和添加100、300、500和700 mg/kg GSH的试验饲料, 饲养56d后采样分析, 并采用氯化铵进行96h氨氮应激试验。结果表明: 除100 mg/kg组外, 饲料中添加GSH显著提高黄颡鱼肝脏、血清GSH含量(P<0.05), 当GSH添加量≥300 mg/kg时, 肝脏和血清GSH含量均呈现稳定状态。随着饲料中谷胱甘肽水平的增加, 血清免疫和肝脏抗氧化指标均呈现先升高后降低的趋势, 其中300和500 mg/kg组溶菌酶与碱性磷酸酶活性、300 mg/kg组免疫球蛋白M与补体4含量、500 mg/kg组酸性磷酸酶活性与对照组相比显著升高(P<0.05)。与对照组和700 mg/kg组相比, 300 mg/kg组肝脏超氧化物歧化酶、过氧化氢酶、谷胱甘肽过氧化酶活性和总抗氧化能力与血清超氧化物歧化酶、谷胱甘肽过氧化酶活性均显著高升高(P<0.05); 且300 mg/kg组血清丙二醛含量显著降低(P<0.05)。氨氮应激96h时, 与对照组相比, 300 mg/kg组肝脏和血清超氧化物歧化酶、过氧化氢酶、谷胱甘肽过氧化酶活性力均显著升高(P<0.05), 且300 mg/kg组血清丙二醛含量显著降低(P<0.05)。由此可见, 饲料中添加谷胱甘肽能提高黄颡鱼幼鱼组织谷胱甘肽含量、免疫及抗氧化性能, 其中以300—500 mg/kg为宜。     

团头鲂幼鱼吡哆醇适宜需求量的研究

试验采用单因素试验设计, 以饲料中吡哆醇浓度为影响因素, 研究了团头鲂幼鱼的适宜吡哆醇需求量。试验共配置了7组等氮等能的半纯化饲料, 其吡哆醇的实际含量分别为0、1.04、1.99、4.07、5.91、7.96和9.22 mg/kg。选用840尾均重:(6.810.17) g团头鲂幼鱼, 随机分为7组, 每组4重复, 每重复30尾鱼, 日投饵3次, 养殖期为8周。结果表明, 当饲料中吡哆醇含量由0升高至5.91 mg/kg时, 团头鲂的增重率、特定生长率、饲料利用率、成活率、蛋白效率比和氮保留率均得到显著改善(P0.05); 当吡哆醇含量进一步升高至9.22 mg/kg时, 蛋白效率比和氮保留率均显著下降(P0.05), 而其他指标则无显著变化(P0.05)。饲料中的吡哆醇含量显著影响团头鲂的肝体比(P0.05)且以5.91 mg/kg组为最低, 但对肥满度和胴体率均无显著影响(P0.05)。当饲料吡哆醇含量由0升高至5.91 mg/kg时, 肝脏谷草转氨酶和谷丙转氨酶活性以及吡哆醇含量均显著升高(P0.05); 当吡哆醇含量进一步升高至9.22 mg/kg时, 三者均无显著变化(P0.05)。以肝脏中的谷丙和谷草转氨酶活性以及吡哆醇含量为评价指标, 拟合折线模型得到团头鲂幼鱼的适宜吡哆醇的需求量为4.175.02 mg/kg。       

异育银鲫幼鱼对饲料中维生素K需求的研究

以不同维生素K水平(0.13、2.15、3.25、6.40、12、17.20和23.20 mg/kg饲料)的7种精制饲料喂养初始体重约为(2.17±0.01) g的异育银鲫(Carassius auratus gibelio)10周, 每个处理3个重复, 研究异育银鲫对维生素K的需求量。结果显示: 饲料中维生素K的添加可以明显降低摄食率, 饲料中维生素K含量为2.15 mg/kg时, 摄食率出现最大值, 之后显著下降(P<0.05), 在12 mg/kg时达到最低值。特定生长率随着维生素K的添加表现出升高的趋势, 饲料中维生素K含量为12 mg/kg时, 出现最大值, 但是差异不显著(P>0.05)。饲料中维生素K的含量从0.13 mg/kg升至3.25 mg/kg时, 饲料效率显著升高(P<0.05), 随着饲料中维生素K的进一步添加, 趋于稳定(P>0.05), 在12 mg/kg时达到最大值, 并且与特定生长率呈正相关关系(SGR=0.01 FE+0.95, R²=0.95)。血液红细胞数目随着饲料维生素K含量的增加先显著升高(P<0.05), 在6.40 mg/kg时达到最大值, 之后趋于稳定(P>0.05)。血红蛋白含量、血球容积比、血清钙含量与血液中红细胞数目表现出相似的趋势, 均在不添加维生素K组出现最低值, 但是差异不显著(P>0.05)。肝体比、肥满度及鱼体生化组成均不受饲料维生素K水平的影响(P>0.05)。分别对饲料效率、红细胞数目进行折线回归得出异育银鲫幼鱼对维生素K的最适需求量为3.73—6.72 mg/kg饲料。     

The immunomodulatory effects of tuftsin on the non-specific immune system of Indian Major carp, Labeo rohita

The purpose of this study was to determine if injections of different dosages of tuftsin would enhance the immune response and disease resistance against the infections due to the opportunistic pathogens Aeromonas hydrophila and Edwardsiella tarda in Labeo rohita fingerlings. Hence, four different dosages of tuftsin in PBS suspension at the rate of 0, 5, 10, 15 mg kg(-1) body weight of fish were injected intraperitoneally to the fingerlings of L. rohita at 2-week intervals for four times. After every 2-week interval, different serum biochemical, haematological and immunological parameters of fish were evaluated. Biochemical and haematological parameters including serum total protein content, albumin content, globulin content, albulin:globulin ratio, glucose content, leucocyte counts etc.; cellular immune parameters including superoxide anion production, phagocytic activities, lymphokine production index etc.; humoral immune parameters including lysozyme activity, complement activity, serum bactericidal activity etc., in the fish were evaluated after every 2-week interval. After 56 days, fish were divided into two subgroups under each major treatment group for challenge with two pathogens A. hydrophila and E. tarda. The mortality (%) and agglutinating antibody titre was recorded on 28th day post challenge. Most of the immune parameters including leucocyte count, phagocytic ratio, phagocytic index, lysozyme activity, complement activity, and serum bactericidal activity were significantly (p相似文献   

Comparative studies on the effect of ergot contaminated feed on performance and health of piglets and chickens

Two dose response trials were conducted with piglets and chickens to study the effects of increasing amounts of ergot (Claviceps purpurea) with a defined alkaloid content and pattern on performance, biochemical serum characteristics and organ weights (of chickens). The ergot was mixed into the cereal-soybean meal based diets at levels of 0, 0.5, 1, 2 and 4?g/kg. The total alkaloid content of the ergot was analysed to be 2775?mg/kg and showed the following composition: ergometrine 8.1%, ergotamine 5.4%, ergocornine 3.2%, α-ergocryptine 1.9%, ergocristine 14.9% and residue 66.5%. Each treatment was tested with eight castrated male and eight female piglets over a period of 35 days (8?kg initial live weight) and 28 male chickens for 21 days (43?g initial live weight). Cumulative daily dry matter intake and live weight gain [g/d] were 595, 535, 560, 577 and 490 and 413, 399, 420, 443 and 347 for the piglets fed the unsupplemented control diet and the diets containing 0.5, 1, 2 and 4?g ergot per kg, respectively. Feed intake and live weight gain of the piglets fed the highest ergot supplemented diet were significantly decreased. Serum aspartate aminotransferase activity of the 4?g ergot treatment was significantly increased. Also serum albumin concentrations showed significant linear alterations. Serum activities of glutamate dehydrogenase, γ-glutamyltransferase, total protein and porcine growth hormone were not significantly influenced by dietary treatment. The experiment with chickens demonstrated no significant effects on performance due to dietary ergot exposure. The serum activities of glutamate dehydrogenase and alanine aminotransferase were not significantly influenced by dietary treatment while serum activities of γ-glutamyltransferase and aspartate aminotransferase and the concentrations of albumin and total bilirubin were significantly affected. Heart weights showed a significant linear decrease due to ergot feeding. According to these results, piglets seemed to react more sensitively on the occurrence of ergot in the diet as compared to chickens. The critical level of total ergot alkaloids for piglets seemed to be in the range from 5.6?mg to 11.1?mg/kg diet for the present study. Ergot effects on signs of inflammation in the proximal duodenum occurred in chickens fed diets containing 2.8?mg and 11.1?mg total ergot alkaloids/kg although live performance remained unaffected. Further studies are necessary to define the critical level of ergot alkaloids in dependence on alkaloid pattern.     

The Effect of Dietary Organic Chromium on Specific Growth Rate, Tissue Chromium Concentrations, Enzyme Activities and Histology in Common Carp, Cyprinus carpio L.

A 63-day feeding trial was carried out to investigate the effect of three levels of Cr yeast (0.5, 1.0 and 2.0?mg Cr/kg) on the utilization of diets containing 38.5?% of maize starch or dextrin in common carp, Cyprinus carpio L. (initial mean body mass 14?±?0.3?g) in an auto circulator system at 25?±?0.5?°C. A two-way analysis of variance (ANOVA) showed that the final body mass (FBM), percentage mass gain (%MG), specific growth rate (SGR) and feed conversion ratio (FCR) were significantly (P?<?0.05) affected by the two sources of variation (carbohydrate source and Cr level). In general, fish fed on a diet containing starch and fortified with 0.5?mg Cr/kg performed significantly higher FBM (47.23?g), %MG (225.11), SGR (1.91) and lower value of FCR (1.24) compared to fish fed on the other diets. Carp fed on 2.0?mg Cr/kg with maize starch and 1.0?mg Cr/kg with dextrin-based diet showed a significant reduction (P?<?0.05) in whole body lipid content as confirmed by a two-way ANOVA. Fish fed on a maize starch-based diet supplemented with 0.5 and 1.0?mg Cr/kg recorded the highest activities for hexokinase enzyme. Glucose-6-phosphate dehydrogenase activity was neither affected by Cr concentration nor by dietary carbohydrate source. Fish fed on dextrin-based diets accumulated higher Cr in the whole tissue compared to fish fed on starch-based diets. Normal histological structures in the liver and gut tissues were observed in all groups. The present data clearly showed that dietary Cr yeast was safe in the fish diet at the levels tested.     

Effect of multiple injections of beta-glucan on non-specific immune response and disease resistance in Labeo rohita fingerlings

The purpose of this study was to determine if multiple injections of different dosages of beta-glucan derived from barley would enhance the immune response and disease resistance against infections due to opportunistic pathogens Aeromonas hydrophila and Edwardsiella tarda in Labeo rohita fingerlings. Hence, four different dosages of beta-glucan suspension in phosphate-buffered saline at the rate of 0, 5, 10, 15 mg kg(-1) body weight of fish were injected intraperitoneally to the fingerlings of Labeo rohita at two-week intervals for four times. After every two-week interval different serum biochemical, haematological and immunological parameters of fish were evaluated. At the end of immunostimulation trial of 56 days, fish were divided into four subgroups under each major treatment group for challenge through i.p injection and bath immersion with two pathogens, A. hydrophila and E. tarda. The mortality (%) and agglutinating antibody titre was recoded on 28th day post challenge. Most of the immune parameters such as leucocyte count, phagocytic ratio, phagocytic index, lysozyme activity, complement activity, serum bactericidal activity were significantly (P < 0.05) enhanced on 42 days after three i.p injections of 10 mg of beta-glucan kg(-1) body wt. Challenge study indicated least mortality in the group of fishes injected with medium dose of 10 mg of beta-glucan kg(-1) body wt. four times. Multiple injections of beta-glucan might have maintained the activation of phagocytic cells for a long period which in turn would lead to long-term protection in fishes. Thus, injections of 10 mg of beta-glucan kg(-1) body wt. for three times can be advocated to enhance the immune response of fish species under aquaculture.     

饲料中不同维生素C含量对长吻鮠的影响

用维生素C含量为38、364 和 630 mg /kg 的三种饲料饲喂初体重为23.19±0.58g的长吻鮠8个月,实验结果表明,38mg/kg Vc饲料组饲喂的长吻鮠表现出了典型的Vc缺乏症状：体色发黑,脊椎侧弯,鳍边由开始的萎缩直到腐烂;贫血;特定生长率显著降低（p＜0.05）。并且38mg/kg Vc饲料组长吻鮠的生理指标也受到影响：血清溶菌酶活性显著下降（p＜0.05）;肝脏的SOD活性及MDA含量均显著升高（p＜0.05）;血清皮质醇没有显著差异（p>0.05）;但各处理组长吻鮠肝脏中均未检测到诱导型HSP70的存在。因此,相对于皮质醇和HSP70,血清溶菌酶、肝脏SOD活性、肝脏MDA含量以及血液理化指标（血红细胞数及血红蛋白）更能反映出Vc缺乏下长吻鮠的生理状态。     

Toxicity profiling of the ethanolic extract of Citrullus lanatus seed in rats: behavioral,biochemical and histopathological aspects

Citrullus lanatus (Cucurbitaceae) is conventionally used for the treatment of urinary tract infection, renal stones, hypertension, diabetes and diarrhoea. Current study evaluates acute and 28 days repeated toxicity ethanolic extract of C. lanatus seed (EECLS) in Wistar rats to measure its safety profile. The single dose (2000 mg/kg BW) of EECLS was administered while in 28 days repeated study 250, 500 and 1000 mg/kg BW were administered orally in rats. Parameters such as biochemical, haematological and histopathological were analysed in subacute toxicity study. During study, no apparent sign of toxicity, behavioural changes and mortality were detected in acutely exposed animals. In 28 days repeated toxicity study, rats did not show significant changes in behaviour, gross pathology, body weight, biochemical and haematological parameters. Abridged serum glucose and cholesterol levels during the study designate their roles in treatment of hyperglycaemic and hyperlipidaemic conditions. No significant difference was observed in histopathology of liver and kidneys of treated rats. The current investigation demonstrated that EECLS is non-toxic below 1000 mg/kg BW and provides protection to some body organs. The data propose that LD₅₀ of EECLS was greater than 2000 mg/kg BW and the no observed adverse effect level (NOAEL) of EECLS was at the dose of 1000 mg/kg in rats. Taken together, our finding suggests that, EECLS is safe and provides some protection to body organs; also, its extract can be used for further preclinical and clinical evaluation for its therapeutic activity.     

Comparison of In Vitro and Vivo Efficacy of Caspofungin Against Candida parapsilosis, C. orthopsilosis, C. metapsilosis and C. albicans

Caspofungin activity was determined in vitro and in vivo against three Candida orthopsilosis, three C. metapsilosis, two C. parapsilosis sensu stricto and two C. albicans isolates. MIC values and killing activity were determined in RPMI-1640 plus 50?% human serum. Neutropenic (cyclophosphamide-treated) mice were infected intravenously. Five-day intraperitoneal treatment with caspofungin was started after 24?h postinfection. Kidney burden was analyzed using the Kruskal-Wallis test with Dunn's post-test. In killing studies, caspofungin was fungistatic and fungicidal against C. albicans at ≥0.25 and ≥2?μg/ml concentrations, respectively. Caspofungin was fungistatic at ≥8-16, ≥2-8 and at ≥2-8?μg/ml against C. parapsilosis, C. orthopsilosis and C. metapsilosis, respectively. In the murine model, C. albicans was inhibited by 1, 2 and 5 mg/kg of caspofungin (P?相似文献   

The mechanism of lack of hypocholesterolemic effects of pravastatin sodium,a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor,in rats

In order to clarify the reason why pravastatin, a 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitor, did not show hypocholesterolemic effects in rats, the changes of various parameters affecting the serum cholesterol levels by pravastatin were determined in rats and rabbits, as a comparison. In rabbits, pravastatin administration at 50 mg/kg for 14 days decreased serum and liver cholesterol by 40% and 8%, respectively. The hepatic LDL receptor activity was increased 1.7-fold, and VLDL cholesterol secretion was decreased. Cholesterol 7α-hydroxylase activity was not changed. In contrast, in rats, serum cholesterol was increased by 14% at 50 mg/kg and 27% at 250 mg/kg for 7 days, respectively. At 250 mg/kg, liver cholesterol was significantly increased by 11%. Under these conditions, neither the hepatic LDL receptor activity nor cholesterol 7α-hydroxylase was changed, and VLDL cholesterol secretion was increased. At 250 mg/kg, net cholesterol synthesis in rat liver was increased after 7 days of consecutive administration. These results imply that in rats, stimulated net cholesterol synthesis caused the increase of liver cholesterol followed by the increase of VLDL cholesterol secretion, and resulted in the raise of plasma cholesterol. Although hepatic HMG-CoA reductase was induced almost the same fold in both animals at 50 mg/kg, the induced HMG-CoA reductase activity in rats might overcome the inhibitory capability of pravastatin, resulting in an increase of net cholesterol synthesis, but not in rabbits. This overresponse to pravastatin in rats might cause the lack of hypocholesterolemic effects of this drug.